Argentina
Lugones Linked the Advance of Clinical Trials to an Agreement to Bring in National Hospitals
The Health minister said clinical research accounts for more than 48% of private investment in R&D in Argentina. He also highlighted an agreement between ANES and Bristol Myers Squibb to improve the participation of public hospitals in those studies.
The Health minister, Mario Lugones, said that clinical research has gained ground in Argentina and maintained that it already accounts for more than 48% of private investment in research and development. He also noted that the number of authorized clinical trials has increased 80% in recent years.
According to reports by Crónica and BAE Negocios, the official stressed that this activity generates skilled employment and contributes to the search for and verification of new treatments for patients.
Lugones also focused on an agreement between ANES and the biopharmaceutical company Bristol Myers Squibb, aimed at enabling national hospitals to have greater participation in this type of study.
According to what was published, the agreement provides for training for professionals, identification of administrative and technical barriers, and standardization of procedures, at no extra cost to the institutions.
In that context, the minister said that, under the leadership of President Javier Milei, the Government is promoting cooperation with the private sector to expand Argentina’s presence in clinical research and in other activities in the field. He also stated that health can function as an engine of economic development, with the capacity to create quality jobs and promote innovation.
Sources
About this note. Written by El Notero with the assistance of artificial intelligence, based on what was published by the cited outlet. El Notero did not conduct its own reporting on this event.
